眼科 ›› 2025, Vol. 34 ›› Issue (2): 158-160.doi: 10.13281/j.cnki.issn.1004-4469.2025.02.012

• 论著 • 上一篇    下一篇

杞黄滴眼剂对实验性干眼角膜上皮损伤的修复作用

刘伯温1  李琦1  刘宏伟2   

  1. 1 北京市隆福医院眼科,北京 100010; 2首都医科大学附属北京同仁医院 北京同仁眼科中心 北京市眼科研究所 眼科学与视觉科学北京市重点实验室,北京 100730
  • 收稿日期:2024-07-19 出版日期:2025-03-25 发布日期:2025-03-13
  • 通讯作者: 刘宏伟,Email:hw65@sohu.com

Repair effect of Qihuang eye drops on corneal epithelial damage in experimental dry eyes

Liu Bowen1, Li Qi1, Liu Hongwei2   

  1. 1 Department of Ophthalmology, Beijing Longfu Hospital, Beijing 100010, China; 2 Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University; Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing 100730, China
  • Received:2024-07-19 Online:2025-03-25 Published:2025-03-13
  • Contact: Liu Hongwei, Email: hw65@sohu.com

摘要:  目的 观察杞黄滴眼剂对实验性干眼角膜上皮损伤的修复作用。设计 实验性研究。研究对象 实验动物大鼠40只。方法 大鼠摘除眶外泪腺并眼内滴注苯扎溴铵溶液,制成角膜上皮损伤模型。造模后第2天,用裂隙灯显微镜检查角膜染色情况,根据染色面积对大鼠双眼角膜损伤进行评分,0分角膜上皮无染色,1、2、3、4分分别为染色面积<25%、25%~50%、>50%~75%、>75%。以各组分值相近为原则分成5组,每组8只16眼,一组作为阴性对照采用溶剂滴眼,其他四组分别使用1.75%、3.5%、7%杞黄滴眼剂和表皮生长因子滴眼液进行治疗。在第7、14和21天,再次根据染色面积对角膜上皮病变进行评分,比较各组治疗后各时间点角膜上皮病变评分。主要指标 角膜上皮病变评分。结果 治疗第7天,7%杞黄滴眼剂组 [(2.38±1.26)分]和表皮生长因子滴眼液组[(2.39±0.85)分]的角膜病变显著轻于溶剂组[(3.19±0.83)分];治疗第14天,1.75%杞黄滴眼剂组[(2.44±0.73)分]、3.5%杞黄滴眼剂组[(2.44±0.78)分]、7%杞黄滴眼剂组[(2.06±1.00)分]和表皮生长因子滴眼液组[(2.28±0.89)分]的角膜病变显著轻于溶剂组[(3.38±1.15)分];治疗第21天,1.75%杞黄滴眼剂组[(2.06±0.68)分]、3.5%杞黄滴眼剂组[(1.83±0.71)分]、7%杞黄滴眼剂组[(1.56±0.63)分]和表皮生长因子滴眼液组[(1.83±0.62)分]的病变显著轻于溶剂组[(2.81±0.83)分]。结论 杞黄滴眼剂对实验性干眼角膜上皮损伤有一定修复作用,3.5%杞黄滴眼剂的治疗效果更好。(眼科,2025,34: 158-160)

关键词: 杞黄滴眼剂, 实验性干眼, 角膜上皮损伤

Abstract: Objective To investigate the reparative effects of Qihuang eye drops on experimental dry eye-induced corneal epithelial injury. Design Experimental study. Participants Forty experimental animal rats. Methods A corneal epithelial injury model was established by excising the extraorbital lacrimal glands and instilling benzalkonium bromide solution. On day 2 post-modeling, corneal staining was assessed via slit-lamp microscopy, and corneal injury was scored based on staining area: 0 (no staining), 1 (<25%), 2 (25%~50%), 3 (>50%~75%), and 4 (>75%). Rats were divided into 5 groups (8 rats, 16 eyes per group) with matched baseline scores. The control group received solvent eye drops, while the other four groups were treated with 1.75%, 3.5%, or 7% Qihuang eye drops, or epidermal growth factor (EGF) eye drops. Corneal epithelial scores were re-evaluated on days 7, 14, and 21. The corneal epithelial lesion scores at various time point after treatment were compared among the groups. Main Outcome Measures Corneal epithelial injury scores. Results On day 7, the 7% Qihuang group (2.38±1.26) and EGF group (2.39±0.85) showed significantly lower scores than the control group (3.19±0.83). On day 14, all Qihuang groups (1.75%: 2.44±0.73; 3.5%: 2.44±0.78; 7%: 2.06±1.00) and the EGF group (2.28± 0.89) exhibited reduced scores compared to the control group (3.38±1.15). By day 21, the Qihuang groups (1.75%: 2.06±0.68; 3.5%: 1.83±0.71; 7%: 1.56±0.63) and EGF group (1.83±0.62) demonstrated further improvement, outperforming the control group (2.81±0.83). Conclusions Qihuang eye drops promote the repair of corneal epithelial injury in experimental dry eye, with the 3.5% concentration showing optimal efficacy of treatment. (Ophthalmol CHN, 2025, 34: 158-160)

Key words: Qihuang eye drops, experimental dry eye, corneal epithelial damage